Semaglutide and NT-proBNP in obesity-related HFpEF
By improving insulin sensitivity and reducing compensatory hyperinsulinaemia, these medications may help address the hormonal imbalances that drive androgen excess
Whatever the exact mechanism may be, its likely the drugs pack a one-two punch, working both on the tumor cells themselves, as well as their environment, he added
They were the first in class approved for the management of overweight and obesity, says Rothberg
Employers and insurers are wary
Before you use any such products, its important to know what they contain, how they work, and whether there is real scientific evidence that they actually help